https://www.reuters.com/business/healthcare-pharmaceuticals/mesoblast-soars-us-fdas-nod-review-lead-drug-candidate-2023-03-08/#:~:text=The%20brokerage%20said%20it%20expects,%241.140%20earlier%20in%20the%20session.
Brokerage Jefferies said it expects "significant" U.S. sales of the drug (nah, therapy) in fiscal 2024.
PS: I will be adding on any pull backs.
This post is not to be construed as investment advice because it is not meant to be.
- Forums
- ASX - By Stock
- MSB
- Significant sales in fiscal 2024
Significant sales in fiscal 2024
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
96.0¢ | 97.0¢ | 91.5¢ | $1.606M | 1.717M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 4455 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 30242 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 58738 | 0.945 |
11 | 35440 | 0.940 |
9 | 108327 | 0.935 |
4 | 20323 | 0.930 |
5 | 71522 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 1335 | 4 |
0.955 | 39100 | 9 |
0.960 | 28613 | 6 |
0.965 | 40450 | 4 |
0.970 | 19796 | 3 |
Last trade - 11.26am 29/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online